{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:12:16Z","timestamp":1778695936541,"version":"3.51.4"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>New studies of chronic obstructive pulmonary disease (COPD) are revealing the key role of airway epithelial cells and innate immune cells in the initiation, exacerbation, and progression of airway disease. An emerging scheme focuses on expansion of airway progenitor epithelial cells that feed forward for a type 2 immune response and consequent IL-13\u2013driven mucus production that is linked to the morbidity and mortality of COPD. Analysis of human airway progenitor epithelial cells and airway tissue shows that IL-13 signaling to MUC5AC mucin gene expression relies on specific activation of mitogen-activated protein kinase 13, providing a druggable target for attenuating mucus production in the setting of viral infection and other inhaled stimuli of airway inflammation. Moreover, structure-based drug design is delivering highly potent, selective, and nontoxic small-molecule kinase inhibitors of mitogen-activated protein kinase 13 that offer a therapeutic strategy to downregulate excess mucus production to a physiological level and thereby achieve a precision medicine solution to the major health care problem of COPD and related airway diseases.<\/jats:p>","DOI":"10.1513\/annalsats.201808-531mg","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T10:35:23Z","timestamp":1544783723000},"page":"S260-S265","source":"Crossref","is-referenced-by-count":9,"title":["Epithelial\u2013Immune Cell Interactions for Drug Discovery in Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"15","author":[{"given":"Shamus P.","family":"Keeler","sequence":"first","affiliation":[{"name":"Drug Discovery Program, Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Gerovac","sequence":"additional","affiliation":[{"name":"Drug Discovery Program, Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangyun","family":"Wu","sequence":"additional","affiliation":[{"name":"Drug Discovery Program, Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Drug Discovery Program, Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua R.","family":"Chartock","sequence":"additional","affiliation":[{"name":"Drug Discovery Program, Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek E.","family":"Byers","sequence":"additional","affiliation":[{"name":"Drug Discovery Program, Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur G.","family":"Romero","sequence":"additional","affiliation":[{"name":"Drug Discovery Program, Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Holtzman","sequence":"additional","affiliation":[{"name":"Drug Discovery Program, Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,12,1]]},"reference":[{"key":"2026020502223762000_bib1","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N Engl J Med"},{"key":"2026020502223762000_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.200612-1772OC","article-title":"Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology","volume":"176","author":"Hogg","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502223762000_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1378\/chest.09-2607","article-title":"Global Initiative for Chronic Obstructive Lung Disease stage 0 is associated with excess FEV1 decline in a representative population sample","volume":"138","author":"Brito-Mutunayagam","year":"2010","journal-title":"Chest"},{"key":"2026020502223762000_bib4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1164\/rccm.201710-2028PP","article-title":"At the root: defining and halting progression of early chronic obstructive pulmonary disease","volume":"197","author":"Martinez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502223762000_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MCP.0000000000000145","article-title":"The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications","volume":"21","author":"Kim","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"2026020502223762000_bib6","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jaci.2018.04.020","article-title":"Biologics and chronic obstructive pulmonary disease","volume":"141","author":"Pavord","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026020502223762000_bib7","first-page":"686","article-title":"Importance of airway inflammation for hyperresponsiveness induced by ozone","volume":"127","author":"Holtzman","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"2026020502223762000_bib8","first-page":"312","article-title":"Experimental airway inflammation and hyperreactivity: searching for cells and mediators","volume":"131","author":"Boushey","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2026020502223762000_bib9","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nri3739","article-title":"The role of airway epithelial cells and innate immune cells in chronic respiratory disease","volume":"14","author":"Holtzman","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2026020502223762000_bib10","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33\u2013producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J Clin Invest"},{"key":"2026020502223762000_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.chest.2017.09.044","article-title":"Triggering receptor expressed on myeloid cells-2 (TREM-2) expression tracks with M2-like macrophage activity and disease severity in COPD","volume":"153","author":"Byers","year":"2018","journal-title":"Chest"},{"key":"2026020502223762000_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI0214345","article-title":"Viral induction of a chronic asthma phenotype and genetic segregation from the acute response","volume":"110","author":"Walter","year":"2002","journal-title":"J Clin Invest"},{"key":"2026020502223762000_bib13","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.4049\/jimmunol.1800671","article-title":"Influenza A virus infection causes chronic lung disease linked to IL-13 and mucin expression at sites of active viral remnants","volume":"201","author":"Keeler","year":"2018","journal-title":"J Immunol"},{"key":"2026020502223762000_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2015.02.024","article-title":"Association between respiratory infections in early life and later asthma is independent of virus type","volume":"136","author":"B\u00f8nnelykke","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2026020502223762000_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI25167","article-title":"Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals","volume":"116","author":"Tyner","year":"2006","journal-title":"J Clin Invest"},{"key":"2026020502223762000_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm1770","article-title":"Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease","volume":"14","author":"Kim","year":"2008","journal-title":"Nat Med"},{"key":"2026020502223762000_bib17","first-page":"A4293","article-title":"A distinct population of non-B, non-T (NBNT) cells express high levels of IL-13 during acute and chronic airway disease after viral infection [abstract]","volume":"179","author":"Byers","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502223762000_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.20141732","article-title":"TREM-2 promotes macrophage survival and lung disease after respiratory viral infection","volume":"212","author":"Wu","year":"2015","journal-title":"J Exp Med"},{"key":"2026020502223762000_bib19","first-page":"283","article-title":"Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma","volume":"7","author":"Kitaguchi","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026020502223762000_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502223762000_bib21","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N Engl J Med"},{"key":"2026020502223762000_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1164\/rccm.201408-1458OC","article-title":"Asthma\u2013COPD overlap: clinical relevance of genomic signatures of type 2 inflammation in COPD","volume":"191","author":"Christenson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502223762000_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1164\/arrd.1984.130.2.214","article-title":"Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure","volume":"130","author":"O\u2019Byrne","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2026020502223762000_bib24","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1084\/jem.20070360","article-title":"Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia","volume":"204","author":"Grayson","year":"2007","journal-title":"J Exp Med"},{"key":"2026020502223762000_bib25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1152\/physiolgenomics.00321.2005","article-title":"Genetic segregation of airway disease traits despite redundancy of chloride channel calcium-activated (CLCA) family members","volume":"25","author":"Patel","year":"2006","journal-title":"Physiol Genomics"},{"key":"2026020502223762000_bib26","doi-asserted-by":"crossref","first-page":"42138","DOI":"10.1074\/jbc.M112.410282","article-title":"Self-cleavage of human CLCA1 by a novel internal metalloprotease domain controls calcium-activated chloride channel activation","volume":"287","author":"Yurtsever","year":"2012","journal-title":"J Biol Chem"},{"key":"2026020502223762000_bib27","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1172\/JCI64896","article-title":"IL-13\u2013induced airway mucus production is attenuated by MAPK13 inhibition","volume":"122","author":"Alevy","year":"2012","journal-title":"J Clin Invest"},{"key":"2026020502223762000_bib28","first-page":"A1308","article-title":"MAPK13 induction co-locates with MUC5AC to mucin granules [abstract]","volume":"197","author":"Gerovac","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020502223762000_bib29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/thoraxjnl-2012-202744","article-title":"Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial","volume":"68","author":"MacNee","year":"2013","journal-title":"Thorax"},{"key":"2026020502223762000_bib30","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1038\/onc.2017.274","article-title":"P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment","volume":"36","author":"Wada","year":"2017","journal-title":"Oncogene"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/15\/Supplement_4\/S260\/66734539\/annalsats_15_supplement_4_s260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/15\/Supplement_4\/S260\/66734539\/annalsats_15_supplement_4_s260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:22:47Z","timestamp":1770276167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/15\/Supplement_4\/S260\/8457057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":30,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2018,12,1]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201808-531mg","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,12,1]]}}}